GMP/GLP Cred FDA-inspected, GMP/GLP compliant lab with USP testing and method development capabilities presents a trusted partner for pharmaceutical, biotech, and chemical customers seeking compliant analytical services.

Expansion Readiness Recent milestone of launching a new website and ongoing capability expansion (USP <467> testing added in 2020) indicates willingness to scale and accommodate increasing test requests from domestic and international clients.

Broad Service Suite Comprehensive analytical portfolio (ICP-OES/ICP-MS metals, residual solvents, water content, DSC/TGA, FTIR/NIR, HPLC, CHN, GC/GC-MS, and method development/qualification) enables one-stop testing for pharmaceutical and chemical projects.

Mid‑Market Focus Revenue range ($1M–$10M) with a small-team structure (2–10 employees) suggests high specialization and potential for high-touch, relationship-driven sales to mid-size pharma/biotech companies and contract manufacturers seeking specialized niche testing.

Global Demand Link Capability to handle domestic and international requests positions the company to pursue global pharmaceutical clients and CROs needing compliant testing across multiple regions, especially where USP and ICH methods are required.